https://www.selleckchem.com/pr....oducts/salvianolic-a
In the multivariate analysis we found no statistically significant difference in overall survival between patients whose donor had fully HLA compatible aged 50 years and older and patients whose donor had haploidentical HLA compatible and aged up to 50 years (p = 0.135). The results obtained in the study show that for patients aged 50 years or older, a donor with haploidentical human leukocyte antigen compatibility and age below 50 years can be chosen without impairing overall survival. The results obtained in the study show
Like
Comment
Share
